My watch list
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonamide family (ATC A10BB).
Additional recommended knowledge
|Oral antidiabetic drugs and Insulin analogs (A10)|
|Sulfonylureas||Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, Tolbutamide|
|Alpha-glucosidase inhibitors||Acarbose, Miglitol, Voglibose|
|Thiazolidinediones (TZD)||Pioglitazone, Rosiglitazone, Troglitazone|
|Meglitinides||Nateglinide, Repaglinide, Mitiglinide|
|Dipeptidyl peptidase-4 (DPP-4) inhibitors||Saxagliptin, Sitagliptin, Vildagliptin|
|Glucagon-like peptide-1 analog||Exenatide|
|Insulin analogs||fast acting (Insulin lispro, Insulin aspart, Insulin glulisine), intermediate-acting (NPH insulin), long acting (Insulin glargine, Insulin detemir)|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tolazamide". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE